semaglutide long term icd 10 Effectiveness and Safety of in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024) Semaglutide cardiovascular outcomes align more

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

My hunger is quieter and I'm losing weight without obsessing

Metformin is not recommended when eGFR is consistently less than 30 mL/min/1.73 m 2 , and in LEADER, SUSTAIN 6 and PIONEER 6, some of those who were not taking metformin had lower eGFRs

Because muscle matters so much in later life, protecting it should be part of the prescription

The only valid comparison is clinical outcome (weight loss, appetite suppression, blood sugar control), not milligram dose